Related News:
- U.S. FDA grants priority review to Roche’s…
- FDA grants priority review to Xolair (omalizumab)…
- WHO grants prequalification of Actemra/RoActemra for…
- WHO grants prequalification of Actemra/RoActemra for…
- European Commission approves Roche’s Tecentriq as…
- FDA approves Roche’s Vabysmo, the first bispecific…